A first-of-its-kind human trial found that daily supplementation with direct butyrate generator ButyraGen® from NutriScience Innovations delivered statistically significant improvements in psychological well-being within 2 weeks. The findings point to the gut-brain axis, the bidirectional communication network linking the digestive tract and the brain as an emerging frontier for mental well-being formulation.
About ButyraGen®
ButyraGen® is a patent-pending complex of tributyrin and a specialised prebiotic fibre blend, designed to directly generate butyrate, a multifunctional short chain fatty acid (SCFA). SCFAs acts as key signalling molecules throughout the body, influencing digestive function, immune activity, metabolic balance, and even cognitive health.
Key findings at a glance
The randomised, double-blind, placebo-controlled six-week study, published in Nutrition and Dietary Supplements, found participants taking ButyraGen® experienced a 12.90% greater reduction in fearfulness and an 18.16% greater improvement in an at-ease state of mind.
Improvements extended beyond mood scores into real-world functional outcomes that impact overall quality of life. Participants reported a 17.15% increase in mental clarity and a 12.16% improvement in sociability.
Men were more than twice as likely to achieve clinically meaningful reductions in anxiety, while younger adults under 40 years of age showed improvements in feelings of hopelessness, helplessness, and depression, suggesting that ButyraGen® supplementation promoted a more positive outlook in this subpopulation. Participants with normal GI function were also twice as likely to see a reduction in depressive feelings.
The fast-acting ingredient was well tolerated, with mild side effects comparable to placebo and no serious adverse events reported.
Understanding the gut-brain connection
ButyraGen® may support psychological well-being through two complementary gut-brain pathways: an indirect route involving vagal, immune, and hormonal signalling, and a direct route involving butyrate’s activity within the brain itself.
In the indirect pathway, butyrate generation improves gut physiology through enhancement of barrier integrity, modulation of local inflammation, and reduction in digestive distress. This in turn supports psychological well-being as a healthier gut environment sends more favourable signals to the brain via the vagus nerve.
In the direct pathway, butyrate is known to cross the blood-brain barrier, where it can influence neuroinflammation, neurotransmitter synthesis, and gene expression. Through these actions, butyrate may directly affect mood regulation, cognitive processes, and stress resilience, independently of improvements in digestive symptoms.
Implications for mental well-being formulations
These findings, combined with prior clinical research showing that ButyraGen® provides rapid relief from digestive discomfort, including belly pain and bloating, suggests a broader role for direct butyrate generation that connects digestive physiology with psychological outcomes.
“This is the first clinical study to show that directly generating butyrate from tributyrin can deliver gut-brain axis benefits that go beyond digestion,” said study co-author and NutriScience Chief Science Officer Dr. Edward Dosz. “By engaging the gut–brain axis, the two-way communication network between the gut and brain, ButyraGen® highlights a new, more holistic approach to whole-body and mental well-being.”
Consumer awareness of the intersection between digestive and cognitive health is growing, as is demand for more holistic, systems-based approaches to managing overall health. For formulators, these results strengthen the scientific foundation for gut-centred strategies as credible and differentiated entry points into the mental well-being category.